Semaglutide Hair Loss: Why It Happens and What It Means

9 min readWritten by Protocol Health Editorial TeamMedically reviewed by Richard Dentico, MDPublished Updated

Semaglutide hair loss is real, uncommon, and usually a shedding pattern called telogen effluvium rather than damage to the follicle. In the Wegovy weight-management trials, 3.3% of semaglutide patients reported hair loss against 1% on placebo, and the FDA label ties those reports to weight reduction. Shedding tends to start a few months after weight starts falling, and in telogen effluvium the follicles stay alive.

Semaglutide Hair Loss: Why It Happens and What It Means
Here’s what we’ll cover

Key takeaways

  • Semaglutide can cause hair loss, but in a minority of patients, and the FDA label links it to weight reduction rather than to a direct effect on hair.
  • Hair loss is a listed side effect of Wegovy, and the label gives exact numbers.
  • Semaglutide causes hair loss mainly through telogen effluvium, a shedding response the scalp mounts after a stress on the body.
  • Semaglutide hair loss usually starts about three to four months after the trigger, which is why it often appears well after the first injection.
  • Hair loss from a GLP-1 medication is usually not permanent when it is telogen effluvium, because the follicles are resting, not destroyed.
  • Compounded semaglutide is not FDA-approved and is not the same as a brand-name product.

The Short Answer

Does Semaglutide Cause Hair Loss?

Semaglutide can cause hair loss, but in a minority of patients, and the FDA label links it to weight reduction rather than to a direct effect on hair. The usual pattern is diffuse shedding a few months after weight starts coming off, not bald patches. Most people on semaglutide never notice it.

So can semaglutide cause hair loss? Yes, sometimes, mostly through the weight loss itself. If shedding is already on your mind, the two-minute health quiz is where a Protocol Health clinician picks it up.

The Label

Is Hair Loss a Side Effect of Wegovy?

Hair loss is a listed side effect of Wegovy, and the label gives exact numbers. In the FDA-approved Wegovy labeling, a pool of the adult weight-management trials reported hair loss in 3.3% of patients on Wegovy against 1% on placebo.

  • Women: 4% on Wegovy against 2% on placebo.
  • Men: 0.9% on Wegovy against 0 on placebo.
  • Adolescents: in a pediatric trial, 4% on Wegovy against no placebo patients.

The label states that hair loss reactions in Wegovy-treated patients were associated with weight reduction, and it lists hair loss among the most common adverse reactions. That is the strongest evidence available that does Wegovy cause hair loss has a real answer: it does, in a small share of patients, mostly women.

Figures from the Adverse Reactions section of the current Wegovy prescribing information on DailyMed. Ozempic and Wegovy contain the same molecule, which is why questions about Ozempic hair loss, including does Ozempic cause hair loss, land on the same data, though the Wegovy trials are the ones that report it this way.

The Mechanism

Why Does Semaglutide Cause Hair Loss?

Semaglutide causes hair loss mainly through telogen effluvium, a shedding response the scalp mounts after a stress on the body. A hair follicle cycles between a growing phase (anagen) and a resting phase (telogen). A large stress, such as rapid weight loss, a sharp drop in calories or protein, illness or surgery, pushes more follicles into rest at the same time. Those hairs fall out together months later.

What Rapid Weight Loss Does to Hair

Rapid weight loss is the trigger semaglutide sets up, because the drug cuts appetite hard and fast. Eating far less can mean less protein, iron, zinc and other nutrients the follicle depends on. A 2015 review of telogen effluvium describes nutritional deficiency among its triggers and notes that working out the cause requires labs to exclude endocrine, nutritional and autoimmune disorders (PMID 26500992).

What Is Not Proven

A direct toxic effect of semaglutide on the follicle is not proven. A 2025 letter in the Journal of Cosmetic Dermatology reviewing the evidence concluded that an association is suggested but definitive proof of causation is lacking, and called for prospective trials (PMID 40087997). In short, semaglutide and hair loss are linked mostly through what the weight loss does, not through the molecule itself.

Timing

When Does Semaglutide Hair Loss Start?

Semaglutide hair loss usually starts about three to four months after the trigger, which is why it often appears well after the first injection. In telogen effluvium, diffuse shedding typically shows up three to four months after the triggering event (PMID 26500992). The delay is the hair cycle: the follicle switches to rest, then holds the old hair for weeks before releasing it.

That delay is why patients often blame the wrong thing. Hair loss with semaglutide tends to peak when the scale is moving fastest, then follow it, which is the timing of a shedding response, not of a new disease. Expect the first sign of semaglutide hair loss in the brush or the shower drain, months in, not in the first week.

Permanence

Is Hair Loss From GLP-1 Permanent?

Hair loss from a GLP-1 medication is usually not permanent when it is telogen effluvium, because the follicles are resting, not destroyed. Once the trigger settles, the follicles generally re-enter the growth phase. How long semaglutide hair loss lasts, and whether it is reversible on any given timeline, varies from person to person, and no one can promise regrowth on a schedule.

Shedding that does not settle needs a closer look, because it may not be telogen effluvium at all. A 2026 meta-analysis found GLP-1 use associated with androgenetic alopecia as well as telogen effluvium (PMID 42621629). Pattern hair loss behaves differently and does not resolve on its own. So the answer to wegovy hair loss will it grow back depends on what kind of hair loss it is, which is a diagnosis, not a guess.

The Research

What Studies Show About GLP-1 Hair Loss

Studies show a consistent association between GLP-1 hair loss and medication use, built mostly on observational data. Three kinds of evidence point the same way.

  • A 2025 retrospective cohort study from the University of Miami dermatology department, published in the Journal of the American Academy of Dermatology, examined GLP-1 receptor agonist use and hair loss (PMID 39863171).
  • A pharmacovigilance analysis of the FDA Adverse Event Reporting System from 2022 to 2023 found alopecia reported disproportionately with semaglutide and tirzepatide (PMID 38925559). Voluntary reports show a signal, not a rate.
  • A 2026 systematic review and meta-analysis of 17 studies, pooling three cohort studies, estimated an odds ratio of 1.40 for non-scarring alopecia with GLP-1 use, and found no significant association with alopecia areata (PMID 42621629).

The limitation runs through all three. Observational studies cannot fully separate the drug from the weight loss, the diet, or the underlying conditions of people prescribed it. So does GLP-1 cause hair loss? The best answer is this: the association is real, the absolute risk in trials is small, and the weight loss is the most likely route.

The meta-analysis authors attribute the association primarily to weight-loss-related nutritional deficiency, which matches the label's wording.

Other Causes

Other Causes of Hair Loss to Rule Out on Semaglutide

Other causes of hair loss are worth ruling out on semaglutide, because the drug is not the only thing that changes when weight drops. Shedding that coincides with a GLP-1 prescription can still be something else.

  • Iron deficiency and low ferritin, common in women and easy to miss.
  • Thyroid disease, under- or overactive.
  • Postpartum shedding, which follows the same telogen pattern.
  • Androgenetic alopecia, a gradual thinning at the crown or part rather than diffuse shedding.
  • Alopecia areata, which causes round, smooth patches and is autoimmune.
  • Other medications, illness or a recent surgery.

A basic workup with labs and a scalp exam separates these. Ruling out other causes of hair loss on semaglutide is what turns a worry into a plan.

Prevention

How to Prevent Hair Loss on GLP-1 Medication

Preventing hair loss on a GLP-1 medication comes down to protecting the inputs the follicle needs while the appetite is quiet. There is no guaranteed method, and none of these is a treatment claim. They reduce the stresses that drive telogen effluvium.

  • Eat enough protein at every meal, even when you are not hungry. The muscle side of this is covered in GLP-1 and muscle loss.
  • Avoid crash-level intake. Semaglutide makes it easy to eat far too little.
  • Check iron, ferritin, thyroid and vitamin D before assuming a supplement will help.
  • Be careful with biotin. High-dose biotin can interfere with some laboratory tests, including thyroid tests, so tell your clinician before bloodwork.
  • Talk with your prescriber about the pace of weight loss rather than changing your dose yourself.

For food specifics, what to eat on semaglutide covers the practical side. People with hair loss on Ozempic, or anyone asking how to stop hair loss from GLP-1 medication or how to stop hair loss from Ozempic specifically, usually need the same thing: steady protein and a slower, supervised pace. Do not stop semaglutide on your own because of shedding; talk to your prescriber first.

Ozempic Face

Semaglutide Hair Loss vs Ozempic Face

Semaglutide hair loss and Ozempic face are separate effects of rapid weight loss, and they need separate conversations. Hair loss is a change in the hair cycle. Ozempic face is volume loss in the facial fat pads, which is covered in Ozempic face and how to prevent it.

When thinning persists after shedding has settled and other causes are ruled out, some patients ask about procedures. Protocol Health offers PRP hair restoration as an in-clinic option to discuss, and what to expect from PRP for hair loss explains the process. Results vary, PRP is not a guaranteed fix, and it does not address the cause of semaglutide hair loss.

At Protocol Health

Semaglutide Hair Loss at Protocol Health

Semaglutide hair loss is a normal topic at Protocol Health, and it belongs in the first visit, not after the shedding starts. Protocol Health prescribes GLP-1 weight-loss medication, including compounded semaglutide, which is a commercial interest worth naming. Compounded semaglutide is not FDA-approved and is not the same product as Wegovy or Ozempic; the FDA has published its concerns about unapproved GLP-1 drugs, and the label figures above come from the brand-name trials.

Care is in person at the Scarsdale, New York clinic, with telehealth for eligible patients in NY, NJ, CT, FL and CA. Pricing depends on your plan, and a consultation is the first step. Start with semaglutide at Protocol Health, or read what medical weight loss involves.

Semaglutide hair loss is usually a temporary side effect of losing weight quickly, and a clinician with your labs can tell you whether yours fits that pattern.

FAQ

Frequently Asked Questions

Does semaglutide cause hair loss?

It can, in a minority of patients. In the Wegovy weight-management trials, 3.3% of semaglutide patients reported hair loss against 1% on placebo, and the label associates it with weight reduction. The usual mechanism is telogen effluvium, a temporary shedding response.

Will my hair grow back after stopping semaglutide?

If the cause is telogen effluvium, the follicles are resting rather than destroyed, and they usually resume growth once the trigger settles. Timing varies and is not guaranteed. Persistent thinning may be a different condition, such as pattern hair loss, and needs evaluation.

How to stop hair loss from semaglutide?

Address the triggers: adequate protein, no crash-level intake, and labs for iron, ferritin and thyroid. Discuss the pace of weight loss with your prescriber rather than changing or stopping the dose yourself. No step guarantees the shedding will stop.

Is GLP-1 hair loss reversible?

GLP-1 hair loss is usually reversible when it is telogen effluvium. A 2026 meta-analysis also linked GLP-1 use to androgenetic alopecia, which does not resolve on its own, so shedding that continues deserves a diagnosis.

Does Ozempic cause hair loss in women more than men?

In the Wegovy trials, which use the same molecule as Ozempic, hair loss was reported in 4% of women against 2% on placebo, and in 0.9% of men against none on placebo. Women reported it more often.

Explore

Related at Protocol Health

Book a weight-loss consultation

Medical disclaimer

This article is for education only and is not medical advice, diagnosis, or treatment. Talk to a licensed clinician before starting, stopping, or changing any medication.

Important safety information

Compounded medications are not FDA-approved and are not the same as brand-name products.

References

  1. FDA-approved Wegovy labeling. National Institutes of Health. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=ee06186f-2aa3-4990-a760-757579d8f77b
  2. PMID 26500992. PubMed. https://pubmed.ncbi.nlm.nih.gov/26500992/
  3. PMID 40087997. PubMed. https://pubmed.ncbi.nlm.nih.gov/40087997/
  4. PMID 42621629. PubMed. https://pubmed.ncbi.nlm.nih.gov/42621629/
  5. PMID 39863171. PubMed. https://pubmed.ncbi.nlm.nih.gov/39863171/
  6. PMID 38925559. PubMed. https://pubmed.ncbi.nlm.nih.gov/38925559/
  7. published its concerns. U.S. Food and Drug Administration. https://www.fda.gov/drugs/drug-alerts-and-statements/fdas-concerns-unapproved-glp-1-drugs-used-weight-loss

Why trust our physicians

Every article is reviewed by a licensed physician on our medical team and is kept current by our editorial team. Read our editorial policy and our medical review process.

Medically reviewed by
Richard Dentico, MD on
Written by
Protocol Health Editorial Team
First published
Last updated

See an error? Email care@protocolhealthmd.com and we will review it.

More on Semaglutide

All Weight Loss articles →